Björn Bolinder - Publications, H-index & Citations

Björn Bolinder

AstraZeneca

12H指数

35论文数

938被引数

收录论文 11

发表时间

Patient-Centered Real-World Evidence Framework for Oncology Product Development 以患者为中心的真实世界证据框架用于肿瘤产品开发

CANCER INVESTIGATION

IF1.9

2025-11-01

PREAI

Medic, Nenad; Filipenko, Dina; Hadi, Monica; Flood, Emuella; McLaurin, Kimmie; Ryan, Kellie; Shenolikar, Rahul; Bolinder, Bjorn

THE SOCIAL VALUE OF IMMUNOTHERAPY IN NON-SMALL CELL LUNG CANCER

VALUE IN HEALTH

IF6

2016-05-01

OAAI

Sullivan, J.; Ward, Sexton A.; Korytowsky, B.; Peneva, D.; Benner, J.; Lakdawalla, D. N.; Bolinder, B.; Figlin, R. A.; Jena, A. B.

COST-EFFECTIVENESS OF CETUXIMAB AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER IN THE UNITED STATES

VALUE IN HEALTH

IF6

2014-05-01

OAAI

Ortendahl, J. D.; Bentley, T. G.; Anene, A. M.; Purdum, A. G.; Bolinder, B.

ANNUAL MEDICAL EXPENDITURE AND MORTALITY RELATED TO ACUTE CORONARY SYNDROME (ACS) IN THE UNITED KINGDOM - A SYSTEMATIC REVIEW

VALUE IN HEALTH

IF6

2011-11-01

OAAI

Zhang, Q.; Jameson, K.; Bolinder, B.; Angeletti, F.; Liczenczias, E.; Neumann, M.; Oberle-ofenheusle, M.; Stern, L.; Yousaf, M.

Cost of hypoglycemia in patients with type 2 diabetes in Sweden 瑞典中2型糖尿病患者低血糖的费用

VALUE IN HEALTH

IF6

2006-05-01

OAAI

Jönsson, L; Bolinder, B; Lundkvist, J

Development and validation, of the economic assessment of glycemic control and long-term effects of diabetes (EAGLE) model

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2006-04-01

PREAI

Mueller, Elvira; Maxion-Bergemann, Stefanie; Gultyaev, Dmitry; Walzer, Stefan; Freemantle, Nick; Mathieu, Chantal; Bolinder, Bjorn; Gerber, Robert; Kvasz, Marion; Bergemann, Rito

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002

CLINICAL THERAPEUTICS

IF3.6

2006-03-01

111

PREAI

Fox, KM; Gerber, RA; Bolinder, B; Chen, J; Kumar, S

Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes

DIABETES CARE

IF16.6

2005-02-01

OAAI

Freemantle, N; Blonde, L; Duhot, D; Hompesch, M; Eggertsen, R; Hobbs, FDR; Martinez, L; Ross, S; Bolinder, B; Stridde, E

Patient satisfaction and glycemic control after 1 year with inhaled insulin (exubera) patients with type 1 or type 2 diabetes

DIABETES CARE

IF16.6

2004-06-01

103

OAAI

Rosenstock, J; Cappelleri, JC; Bolinder, B; Gerber, RA

An analysis of the relationship between rapid transition to insulin, area under the curve for HbA1C measures across time and diabetes-related complications: A Germany population based study

VALUE IN HEALTH

IF6

2003-11-01

OAAI

Simons, WR; Bolinder, B; Vinod, H

Cost analysis of diabetes treatment with glargine insulin or NPH insulin in Spain

VALUE IN HEALTH

IF6

2003-05-01

OAAI

Rubio-Terrés, C; Rodriguez, J; Bolinder, B

研究方向